Close to the Bedside: A Systematic Review of Endogenous Retroviruses and Their Impact in Oncology
- 29 March 2019
- journal article
- review article
- Published by Elsevier in Journal of Surgical Research
- Vol. 240, 145-155
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health (T32 CA163177)
This publication has 118 references indexed in Scilit:
- Transcriptional Profiling of Human Endogenous Retrovirus Group HERV-K(HML-2) Loci in MelanomaGenome Biology and Evolution, 2013
- Human endogenous retroviral K element encodes fusogenic activity in melanoma cellsJournal of Carcinogenesis, 2013
- Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis diseaseMultiple Sclerosis Journal, 2012
- Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast TumorsJNCI: Journal of the National Cancer Institute, 2012
- Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast CancerGenes & Cancer, 2011
- Inactivation of the von Hippel–Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancerOncogene, 2011
- Human RNA “Rumor” Viruses: the Search for Novel Human Retroviruses in Chronic DiseaseMicrobiology and Molecular Biology Reviews, 2008
- Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast CancerJournal of Virology, 2008
- Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cellsJournal of Clinical Investigation, 2008
- Syncytin is involved in breast cancer-endothelial cell fusionsCellular and Molecular Life Sciences, 2006